ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
39 969,00
0,25%
DAX
18 704,42
-0,11%
Brent Oil
83,765
0,67%
Bitcoin
67 041,18
2,76%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ovid Therapeutics Inc (OVID)

  7. Ovid Therapeutics Inc (OVID) Actualités

OVID

Ovid Therapeutics (OVID)

Ovid Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OVID
DateHeureSourceTitreSymboleSociété
14/05/202423h19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OVIDOvid Therapeutics Inc
14/05/202414h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
14/05/202414h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
14/05/202414h00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
13/05/202413h00GlobeNewswire Inc.Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:OVIDOvid Therapeutics Inc
04/04/202414h00GlobeNewswire Inc.Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:OVIDOvid Therapeutics Inc
08/03/202414h24Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:OVIDOvid Therapeutics Inc
08/03/202414h00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
28/02/202414h00GlobeNewswire Inc.Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:OVIDOvid Therapeutics Inc
27/02/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
14/02/202417h10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:OVIDOvid Therapeutics Inc
06/02/202414h00GlobeNewswire Inc.Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:OVIDOvid Therapeutics Inc
01/12/202313h30GlobeNewswire Inc.Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)NASDAQ:OVIDOvid Therapeutics Inc
16/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OVIDOvid Therapeutics Inc
15/11/202322h11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OVIDOvid Therapeutics Inc
03/11/202321h08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OVIDOvid Therapeutics Inc
03/11/202313h00GlobeNewswire Inc.Ovid Therapeutics Reports Third Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:OVIDOvid Therapeutics Inc
18/10/202314h00GlobeNewswire Inc.Ovid Therapeutics and Ligand Pharmaceuticals Enter into a $30 Million Agreement for a 13% Interest in Soticlestat Royalties and Milestones Extending Ovid’s Cash Runway into 2026NASDAQ:OVIDOvid Therapeutics Inc
10/10/202314h00GlobeNewswire Inc.Ovid Therapeutics to Present at the Jefferies Biotech CNS/Neuro SummitNASDAQ:OVIDOvid Therapeutics Inc
26/09/202313h30GlobeNewswire Inc.Ovid Therapeutics to Host Investor Event - R&D Day on Monday, October 2, 2023NASDAQ:OVIDOvid Therapeutics Inc
20/09/202313h30GlobeNewswire Inc.Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:OVIDOvid Therapeutics Inc
30/08/202314h00GlobeNewswire Inc.Ovid Therapeutics to Participate in Upcoming September Investor ConferencesNASDAQ:OVIDOvid Therapeutics Inc
04/08/202314h00GlobeNewswire Inc.Ovid Therapeutics Reports Second Quarter 2023 Financial Results and Corporate UpdatesNASDAQ:OVIDOvid Therapeutics Inc
01/08/202314h00GlobeNewswire Inc.Ovid Therapeutics to Present at the BTIG Virtual Biotechnology Conference 2023NASDAQ:OVIDOvid Therapeutics Inc
31/07/202323h21Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:OVIDOvid Therapeutics Inc
28/06/202314h00GlobeNewswire Inc.Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy OfficerNASDAQ:OVIDOvid Therapeutics Inc
26/06/202314h00GlobeNewswire Inc.Ovid Therapeutics Added to Russell 3000® IndexNASDAQ:OVIDOvid Therapeutics Inc
09/06/202314h55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OVIDOvid Therapeutics Inc
05/05/202323h30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OVIDOvid Therapeutics Inc
05/05/202315h24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OVIDOvid Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OVID

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
VIV
Vivendi
EU
BNP
BNP Paribas
NASDAQ
MSFT
Microsoft
EU
EN
Bouygues
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
COIN
ETHUSD
Ethereum
NYSE
KO
Coca Cola
NYSE
NKE
Nike
EU
AI
Air Liquide
EU
DG
Vinci
SPI
SP500
S&P 500
NASDAQ
GOOGL
Alphabet
EU
ORA
Orange
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés